Company Filing History:
1 out of 3,540 
1 out of 937 
1 out of 975 
Years Active: 2012
Title: Elaine Jaffe: Innovator in Lymphoma Research
Introduction
Elaine Jaffe is a prominent inventor known for her significant contributions to the field of lymphoma research. Based in Great Falls, VA, she has developed innovative methods that enhance the identification and diagnosis of lymphoproliferative disorders. Her work has the potential to improve patient outcomes through more accurate survival predictions.
Latest Patents
Elaine Jaffe holds a patent for "Methods for identifying, diagnosing, and predicting survival of lymphomas." This invention utilizes gene expression data to provide a basis for more accurate identification and diagnosis of lymphoproliferative disorders. The patent discloses a novel microarray, the Lymph Dx microarray, which is designed to obtain gene expression data from lymphoma samples. Additionally, it outlines various methods for utilizing this data to determine the identity of specific lymphomas and predict survival in diagnosed subjects. This information is crucial for developing tailored therapeutic approaches for patients.
Career Highlights
Throughout her career, Elaine Jaffe has worked with esteemed organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and the University of Nebraska. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Elaine has collaborated with notable colleagues such as Louis M. Staudt and George Wright. These partnerships have furthered her research and expanded the impact of her innovations in lymphoma diagnosis and treatment.
Conclusion
Elaine Jaffe's work in lymphoma research exemplifies the importance of innovation in medical science. Her patented methods and collaborations have the potential to significantly improve the diagnosis and treatment of lymphoproliferative disorders.